Detalhe da pesquisa
1.
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Nature
; 511(7508): 246-50, 2014 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24909994
2.
Defining the mode of tumour growth by clonal analysis.
Nature
; 488(7412): 527-30, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22854777
3.
A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours.
Nature
; 478(7369): 399-403, 2011 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22012397
4.
Conditional deletion of PTEN in peripheral T cells augments TCR-mediated activation but does not abrogate CD28 dependency or prevent anergy induction.
J Immunol
; 191(4): 1677-85, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23851688
5.
Beta-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-γ1 phosphorylation.
J Immunol
; 186(2): 784-90, 2011 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21149602
6.
Costimulatory and coinhibitory receptors in anti-tumor immunity.
Immunol Rev
; 229(1): 126-44, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19426219
7.
TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in mice.
J Clin Invest
; 133(4)2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512425
8.
A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
Proc Natl Acad Sci U S A
; 106(52): 22211-6, 2009 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-20007782
9.
Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery.
Cancer Immunol Immunother
; 60(2): 273-81, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21076828
10.
Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies.
Mol Cancer Ther
; 20(1): 121-131, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277440
11.
Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors.
Cancer Immunol Res
; 8(1): 32-45, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806638
12.
Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy.
Mol Cancer Ther
; 17(12): 2530-2542, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30232146
13.
15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism.
Prostaglandins Other Lipid Mediat
; 80(3-4): 136-43, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16939878
14.
Highly successful therapeutic vaccinations combining dendritic cells and tumor cells secreting granulocyte macrophage colony-stimulating factor.
Cancer Res
; 64(22): 8435-42, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15548715
15.
Assessment of in vivo chemotherapy-induced DNA damage in a p53-mutated rat tumor by micronuclei assay.
Ann N Y Acad Sci
; 1010: 775-9, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15033826
16.
Deciphering tumor growth by clonal analysis.
Crit Rev Oncog
; 19(5): 317-25, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25404147
17.
Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo.
J Exp Med
; 209(12): 2157-63, 2012 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23129747
18.
Long live sox2: sox2 lasts a lifetime.
Cell Stem Cell
; 9(4): 283-4, 2011 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21982223
19.
Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
J Immunother
; 32(2): 140-4, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19238012
20.
Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.
Cancer Immunol Immunother
; 57(12): 1745-56, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18369621